Transfusion management of severe anaemia in African children: a consensus algorithm.


Journal

British journal of haematology
ISSN: 1365-2141
Titre abrégé: Br J Haematol
Pays: England
ID NLM: 0372544

Informations de publication

Date de publication:
06 2021
Historique:
received: 06 01 2021
accepted: 18 02 2021
pubmed: 7 5 2021
medline: 28 9 2021
entrez: 6 5 2021
Statut: ppublish

Résumé

The phase III Transfusion and Treatment of severe anaemia in African Children Trial (TRACT) found that conservative management of uncomplicated severe anaemia [haemoglobin (Hb) 40-60 g/l] was safe, and that transfusion volume (20 vs. 30 ml/kg whole blood equivalent) for children with severe anaemia (Hb <60 g/l) had strong but opposing effects on mortality, depending on fever status (>37·5°C). In 2020 a stakeholder meeting of paediatric and blood transfusion groups from Africa reviewed the results and additional analyses. Among all 3196 children receiving an initial transfusion there was no evidence that nutritional status, presence of shock, malaria parasite burden or sickle cell disease status influenced outcomes or modified the interaction with fever status on volume required. Fever status at the time of ordering blood was a reliable determinant of volume required for optimal outcome. Elevated heart and respiratory rates normalised irrespective of transfusion volume and without diuretics. By consensus, a transfusion management algorithm was developed, incorporating three additional measurements of Hb post-admission, alongside clinical monitoring. The proposed algorithm should help clinicians safely implement findings from TRACT. Further research should assess its implementation in routine clinical practice.

Identifiants

pubmed: 33955552
doi: 10.1111/bjh.17429
pmc: PMC7611319
mid: EMS130214
doi:

Types de publication

Clinical Trial, Phase III Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1247-1259

Subventions

Organisme : Wellcome Trust
ID : 202800/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_00004/05
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/J012483/1
Pays : United Kingdom

Investigateurs

Bodo Bongomin (B)
Eva Nabawanuka (E)
Philippa Musoke (P)
Ritah Nasiima (R)
Hellen Mnjalla (H)
Christabel Mogaka (C)
Abubakarr Bah (A)
Christian Umuhoza (C)
William K A Obeng (WKA)
Charlyne Kilba (C)
John Appiah (J)
Ismail Ticklay (I)
Russel Ware (R)
Roberta Petrucci (R)
E T Mberi (ET)
Claude T Tagny (CT)
Saliou Diop (S)
Faten Moftah (F)
Michael E Acquah (ME)
Philip Olatunji (P)
Magdalena Lyimo (M)
Ludovic Anani (L)
Shirley O Ofori (SO)
Charles Engoru (C)

Informations de copyright

© 2021 The Authors. British Journal of Haematology published by British Society for Haematology and John Wiley & Sons Ltd.

Références

BMC Med. 2015 Feb 02;13:21
pubmed: 25640706
PLoS Med. 2012;9(8):e1001297
pubmed: 22927801
N Engl J Med. 2011 Jun 30;364(26):2483-95
pubmed: 21615299
Trials. 2015 Dec 29;16:593
pubmed: 26715196
PLoS Med. 2012;9(9):e1001309
pubmed: 22984355
Clin Lab Med. 1996 Dec;16(4):895-906
pubmed: 8974201
N Engl J Med. 2019 Aug 1;381(5):407-419
pubmed: 31365799
BMC Med. 2014 Apr 25;12:67
pubmed: 24767094
Arch Dis Child. 2005 Jul;90(7):724-8
pubmed: 15970617
N Engl J Med. 2019 Aug 1;381(5):420-431
pubmed: 31365800
Wellcome Open Res. 2019 Feb 8;4:27
pubmed: 31633055
Clin Infect Dis. 2017 Apr 1;64(7):939-946
pubmed: 28362936
Pediatr Crit Care Med. 2018 Sep;19(9S Suppl 1):S98-S113
pubmed: 30161064
Vox Sang. 2019 May;114(4):340-348
pubmed: 30838664
BMC Health Serv Res. 2018 Jul 18;18(1):566
pubmed: 30021576

Auteurs

Kathryn Maitland (K)

Department of Infectious Disease, Division of Medicine, Institute of Global Health and Innovation, Imperial College, London, UK.
Uganda Blood Transfusion Services (BTS), National BTS, Kampala, Uganda.

Sarah Kiguli (S)

Department of Paediatrics and Child Health, School of Medicine, Makerere University and Mulago Hospital, Kampala, Uganda.

Peter Olupot-Olupot (P)

Faculty of Health Sciences, Busitema University, Mbale Regional Referral Hospital, Mbale, Uganda.

Robert O Opoka (RO)

Department of Paediatrics and Child Health, School of Medicine, Makerere University and Mulago Hospital, Kampala, Uganda.

Yami Chimalizeni (Y)

College of Medicine, Malawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.

Florence Alaroker (F)

Soroti Regional Referral Hospital, Soroti, Uganda.

Sophie Uyoga (S)

Kenya Medical Research Institute (KEMRI)/Wellcome Trust Research Programme, Kilifi, Kenya.

Dorothy Kyeyune-Byabazaire (D)

Uganda Blood Transfusion Services (BTS), National BTS, Kampala, Uganda.

Bridon M'baya (B)

Malawi BTS, Blantyre, Malawi.

Imelda Bates (I)

Liverpool School of Tropical Medicine, Liverpool, UK.

Thomas N Williams (TN)

Department of Infectious Disease, Division of Medicine, Institute of Global Health and Innovation, Imperial College, London, UK.
Kenya Medical Research Institute (KEMRI)/Wellcome Trust Research Programme, Kilifi, Kenya.

Deogratias Munube (D)

Department of Paediatrics and Child Health, School of Medicine, Makerere University and Mulago Hospital, Kampala, Uganda.

Dora Mbanya (D)

Haematology & Transfusion Service, Centre Hospitalier et Universitaire, Yaounde, Cameroon.

Elizabeth M Molyneux (EM)

College of Medicine, Malawi-Liverpool-Wellcome Research Programme, Blantyre, Malawi.

Annabelle South (A)

Medical Research Council Clinical Trials Unit (MRC CTU), University College London, London, UK.

A Sarah Walker (AS)

Medical Research Council Clinical Trials Unit (MRC CTU), University College London, London, UK.

Diana M Gibb (DM)

Medical Research Council Clinical Trials Unit (MRC CTU), University College London, London, UK.

Elizabeth C George (EC)

Medical Research Council Clinical Trials Unit (MRC CTU), University College London, London, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH